Philipp Kroneberg,Bernhard Mullinger,Harm A.W.N. Tiddens,Marije van den Beukel-Bakker
申请号：
US13497504
公开号：
US20130034534A1
申请日:
2010.09.29
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A method for treatment of patients with cystic fibrosis by providing an inhalable aerosol comprising a mucolytic compound (dornase alpha) administered into a patients lungs according to a specific treatment protocol setting comprising a mucolytic drug containing aerosol having particles with a predetermined mass medial aerodynamic diameter (MMAD) delivered predominantly to a peripheral lungs using a nebulizing system able to administer said aerosol with overpressure and under controlled breathing conditions.
